🇺🇸 Amlodipine/Olmesartan in United States

188 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Diarrhoea — 30 reports (15.96%)
  2. Fatigue — 22 reports (11.7%)
  3. Nausea — 21 reports (11.17%)
  4. Pain — 20 reports (10.64%)
  5. Drug Ineffective — 19 reports (10.11%)
  6. Dizziness — 18 reports (9.57%)
  7. Death — 16 reports (8.51%)
  8. Headache — 16 reports (8.51%)
  9. Anxiety — 13 reports (6.91%)
  10. Confusional State — 13 reports (6.91%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is Amlodipine/Olmesartan approved in United States?

Amlodipine/Olmesartan does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Amlodipine/Olmesartan in United States?

Radboud University Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.